US 7625563
Cancer treatment methods using selected immunoconjugates for binding to aminophospholipids
granted A61KA61K2039/505A61K39/395
Quick answer
US patent 7625563 (Cancer treatment methods using selected immunoconjugates for binding to aminophospholipids) held by The Board of Regents of the University of Texas System expires Mon Nov 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Dec 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 43
- CPC classes
- A61K, A61K2039/505, A61K39/395, A61K39/39558, A61K47/62